Yohimbine

DB01392ApprovedInvestigationalVet approvedWithdrawnSmall moleculeAdrenergic alpha-Antagonists

Yohimbine is an alpha-2-adrenergic blocker and sympatholytic found in supplements used to. A plant alkaloid with alpha-2-adrenergic blocking activity.

Chemical structure of Yohimbine
Mechanism
Curator reviewed
Primary indication
Indicated as a sympatholytic and mydriatic.Curator reviewed · 1 structured indication
Formula / weight
C21H26N2O3 · 354.4427 g/mol (avg)
First approval
Canada, 2009
Also known as
Yohimbic acid methyl ester

Resolves to

Structure
InChIKeyBLGXFZZNTVWLAY-SCYLSFHTSA-NSMILES[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2

What you can answer from here — as of September 23, 2026

12Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,328Drug interactionsStructured to mechanism, not free text
Sign in
28Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
8ContraindicationsEach with its own population and attribute set
Sign in
12Marketed productsAcross 3 countries and 8 labellers
Sign in
1ATC codeIncluding every combination product, plus 38 drug categories
Sign in
48+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Yohimbine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account